IGF2BP1 and osteosarcoma: In osteosarcoma-derived U2OS and ovarian carcinoma-derived ES-2 cells, decreased MAPK4 mRNA translation mediates the prometastatic effect of IGF2BP1, suggesting that MAPK4 acts as a tumour suppressor [39].